These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35999133)

  • 21. In vivo efficacy of endothelial growth medium stimulated mesenchymal stem cells derived from patients with critical limb ischemia.
    Al-Rifai R; Nguyen P; Bouland N; Terryn C; Kanagaratnam L; Poitevin G; François C; Boisson-Vidal C; Sevestre MA; Tournois C
    J Transl Med; 2019 Aug; 17(1):261. PubMed ID: 31399109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of autologous transplantation of bone marrow cells concentrated with the MarrowXpress system in patients with critical limb ischemia.
    Maione C; Botti C; Coppola CA; Silvestroni C; Lillo S; Schiavone V; Sica G; Sica V; Kumar V; Cobellis G
    Transplant Proc; 2013; 45(1):402-6. PubMed ID: 23375329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of mouse adipose- and bone marrow mesenchymal stem cells in diabetic model with critical limb ischemia.
    Asadi-Yousefabad SL; Nammian P; Sheikhha MH; Tabei SMB; Daneshi S; Nikukar H; Lotfi M; Razban V
    Cell Tissue Bank; 2022 Dec; 23(4):923-936. PubMed ID: 35590084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type 1 Diabetes Mellitus Donor Mesenchymal Stromal Cells Exhibit Comparable Potency to Healthy Controls In Vitro.
    Davies LC; Alm JJ; Heldring N; Moll G; Gavin C; Batsis I; Qian H; Sigvardsson M; Nilsson B; Kyllonen LE; Salmela KT; Carlsson PO; Korsgren O; Le Blanc K
    Stem Cells Transl Med; 2016 Nov; 5(11):1485-1495. PubMed ID: 27412884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethnic minorities with critical limb ischemia derive equal amputation risk reduction from autologous cell therapy compared with whites.
    Wang SK; Green LA; Gutwein AR; Drucker NA; Babbey CM; Gupta AK; Fajardo A; Motaganahalli RL; Wilson MG; Murphy MP
    J Vasc Surg; 2018 Aug; 68(2):560-566. PubMed ID: 29503004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous bone marrow stem cell transplantation in critical limb ischemia: a meta-analysis of randomized controlled trials.
    Liu FP; Dong JJ; Sun SJ; Gao WY; Zhang ZW; Zhou XJ; Yang L; Zhao JY; Yao JM; Liu M; Liao L
    Chin Med J (Engl); 2012 Dec; 125(23):4296-300. PubMed ID: 23217403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial effects of VEGF secreted from stromal cells in supporting endothelial cell functions: therapeutic implications for critical limb ischemia.
    Cobellis G; Maione C; Botti C; Coppola A; Silvestroni A; Lillo S; Schiavone V; Molinari AM; Sica V
    Cell Transplant; 2010; 19(11):1425-37. PubMed ID: 20587143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data.
    Rojewski MT; Lotfi R; Gjerde C; Mustafa K; Veronesi E; Ahmed AB; Wiesneth M; Körper S; Sensebé L; Layrolle P; Hellem S; Schrezenmeier H
    Cytotherapy; 2019 Apr; 21(4):468-482. PubMed ID: 30926359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia.
    Gupta PK; Chullikana A; Parakh R; Desai S; Das A; Gottipamula S; Krishnamurthy S; Anthony N; Pherwani A; Majumdar AS
    J Transl Med; 2013 Jun; 11():143. PubMed ID: 23758736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth kinetics and self-renewal of human mesenchymal stem cells derived from bone marrow of children with oncohematological diseases during expansion in vitro.
    Isaikina Y; Kustanovich A; Svirnovski A
    Exp Oncol; 2006 Jun; 28(2):146-51. PubMed ID: 16837907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atorvastatin Treatment Significantly Increased the Concentration of Bone Marrow-Derived Mononuclear Cells and Transcutaneous Oxygen Pressure and Lowered the Pain Scale after Bone Marrow Cells Treatment in Patients with "No-Option" Critical Limb Ischaemia.
    Kyselovic J; Adamičková A; Gažová A; Valášková S; Chomaničová N; Červenák Z; Madaric J
    Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of autologous bone marrow mononuclear cells in six patients with advanced chronic critical limb ischemia as a result of diabetes: our experience.
    Subrammaniyan R; Amalorpavanathan J; Shankar R; Rajkumar M; Baskar S; Manjunath SR; Senthilkumar R; Murugan P; Srinivasan VR; Abraham S
    Cytotherapy; 2011 Sep; 13(8):993-9. PubMed ID: 21671823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous Autologous Bone Marrow-derived Mesenchymal Stromal Cells Delay Acute Respiratory Distress Syndrome in Swine.
    Batchinsky AI; Roberts TR; Antebi B; Necsoiu C; Choi JH; Herzig M; Cap AP; McDaniel JS; Rathbone CR; Chung KK; Cancio LC
    Am J Respir Crit Care Med; 2023 Dec; 208(12):1283-1292. PubMed ID: 37797214
    [No Abstract]   [Full Text] [Related]  

  • 34. Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia.
    Moazzami K; Majdzadeh R; Nedjat S
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008347. PubMed ID: 22161427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials.
    Teraa M; Sprengers RW; van der Graaf Y; Peters CE; Moll FL; Verhaar MC
    Ann Surg; 2013 Dec; 258(6):922-9. PubMed ID: 23426345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous bone marrow mononuclear cell therapy for critical limb ischemia is effective and durable.
    Liang TW; Jester A; Motaganahalli RL; Wilson MG; G'Sell P; Akingba GA; Fajardo A; Murphy MP
    J Vasc Surg; 2016 Jun; 63(6):1541-5. PubMed ID: 27021379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Administration of Adult Human Bone Marrow-Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger's Disease: Phase II Study Report Suggests Clinical Efficacy.
    Gupta PK; Krishna M; Chullikana A; Desai S; Murugesan R; Dutta S; Sarkar U; Raju R; Dhar A; Parakh R; Jeyaseelan L; Viswanathan P; Vellotare PK; Seetharam RN; Thej C; Rengasamy M; Balasubramanian S; Majumdar AS
    Stem Cells Transl Med; 2017 Mar; 6(3):689-699. PubMed ID: 28297569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
    Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
    Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limb salvage using intramuscular injection of unfractionated autologous bone marrow mononuclear cells in critical limb ischemia: a prospective pilot clinical trial.
    Gabr H; Hedayet A; Imam U; Nasser M
    Exp Clin Transplant; 2011 Jun; 9(3):197-202. PubMed ID: 21649569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies.
    Qadura M; Terenzi DC; Verma S; Al-Omran M; Hess DA
    Stem Cells; 2018 Feb; 36(2):161-171. PubMed ID: 29226477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.